| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $4.81B | +21.7% |
| Cost of Revenue | $1.22B | +22.9% |
| Gross Profit | $3.59B | +21.3% |
| R&D Expense | $1.38B | +28.6% |
| SG&A Expense | $670.3M | +39.0% |
| Operating Income | -$293.3M | -143.5% |
| Pre-tax Income | -$127.0M | -332.9% |
| Income Tax | $34.2M | -52.0% |
| Net Income | -$162.5M |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.23B | +21.0% |
| Accounts Receivable | $1.36B | +20.7% |
| Current Assets | $7.42B | +21.4% |
| Total Assets | $11.09B | +27.4% |
| Current Liabilities | $4.18B | +20.9% |
| Long-term Debt | $745.5M | +0.2% |
| Total Liabilities | $6.61B | +22.9% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.61B | +16.7% |
| Capital Expenditures | $302.1M | +18.5% |
| Investing Cash Flow | -$764.5M | -42.5% |
| Financing Cash Flow | $132.5M | +23.5% |
| Free Cash Flow | $1.31B | +16.3% |
| -743.2% |
| EPS (Basic) | -$0.65 | -712.5% |
| EPS (Diluted) | -$0.65 | -712.5% |
| Stockholders' Equity |
| $4.43B |
| +35.0% |